99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: Comparison of spet and planar images in the detection of primary tumours and axillary lymph node involvement

Nuclear Medicine Communications

Volumn 18, Issue 9, 1997, Pages 839-845

  Schillaci, Orazio ^a   Scopinaro, F ^a   Danieli, R ^a   Tavolaro, R ^a   Picardi, V ^a   Cannas, P ^a   Colella, A C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; MAMMOGRAPHY; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICS; BREAST CARCINOMA; BREAST LESION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; MAJOR CLINICAL STUDY;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030608984     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199709000-00007     Document Type: Article

References (32)

1. 201T1. Clin Nucl Med 1992; 17: 171-176.
2. Podolof DA. Thallium-201 chloride and technetium-99m sestamibi in tumour imaging. In: Henkin RE, Boles MA, Dillehay GL et al., eds. Nuclear medicine. St. Louis, MO: C.V. Mosby, 1996: 1493-1503.
3. 99mTc-SestaMIBI in oncology. Tumori 1996; 82: 12-21.
4. Carvalho PA, Chiu ML, Kronauge JF et al. Subcellular distribution and analysis of Tc-99m MIBi in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1521.
5. Delmon-Mongeon LI, Piwinica-Worms D, Van der Abbeele AD et al. Uptake of the cation hexakis (2-methoxyisobutyl-isonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.
6. Maublant J, Zhang Z, Rapp M et al. In vitro uptake of tech-netium-99m-teboroxime in carcinoma cell lines and normal cells: Comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993; 34: 1949-1952.
7. Scopinaro F, Schillaci O, Scarpini M ct at. Technetium-99m sestamibi: An indicator of breast cancer invasiveness. Eur J Nucl Med 1994; 21: 984-987.
8. Maublant J, de Latour M, Mestas D et al. Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. I Nucl Med 1996; 37: 922-925.
9. Khalkhali I, Mena I, Jouanne E et al. Prone scintimammo-graphy in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994; 178: 491-497.
10. Aktolun C. Technetium-99m sestamibi imaging in breast cancer: An alternative to thallium-201 imaging. J Nucl Med 1994; 35: 2055-2056.
11. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. F.ur J Nucl Med 1994; 21: 432-436.
12. m-MIBI: A comparative study with mammography and ultrasonography. Nucl Med Common 1994; 15: 604-612.
13. m-MIBl mammoscin-tigraphy of breast masses: Early and delayed imaging. Nucl Med Commun 1995; 16: 150-156.
14. Khalkhali I, Cutrone JA, Mena IG et al. Scintimammog-raphy: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast cancer. Radiology 1995; 196: 421-426.
15. Taillefer R, Robidoux A, Lambert Ret al. Teehnetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-1765.
16. Palmedo H, Schomburg A, Grunwald F et al. Technetium-99m-MIBl scintimammography for suspicious breast lesions. I Nucl Med 1996; 37: 626-630.
17. Villanueva-Meyer J, Leonard Jr MH, Briscoe E et al. Mam-moscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 1996; 37: 926-930.
18. Khalkhali I, Mena J, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: A role for the diagnosis of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 357-362.
19. Aktolun C. Exaggerated role of prone technique in breast cancer imaging with technetium-99m methoxyisobutylisonitrile. Eur I Nucl Med 1994; 21: 1257-1259.
20. Khalkhali I, Cutrone I, Mena I et al. Technetium-99m-sestamibi scintimammography of breast lesions: Clini-cal and pathological follow-up. J Nucl Med 1995; 36: 1784-1789.
21. Aktolun C. What is the best technique for patient positioning during breast scintigraphy? J Nncl Med 1996; 37: 2098-2099.
22. Kramer EL, Sanger JJ, Walsh CW Contribution of SPECT to imaging of gastrointestinal adenocarcinoma with 111 In labeled anti-CEA monoclonal antibody. AIR 1988; 151: 697-703.
23. Matsuno S, Tanabo M, Kawasaki Y et al. Effectiveness of planar images and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer. Eur J Nucl Med 1992; 19: 86-95.
24. Aktolun C, Bayhan H, Pabuccu Y et al. Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: Comparison with CT scan. Eur J Nucl Med 1994; 321: 973-979.
25. Schillaci O, Volpino P, Tavolaro R et al. Detection of primary lung cancer with technetium-99m-tetrofosmin. J Nucl Med 1996; 37: 35P-36P.
26. Schillaci O, Scopinaro F, Angeletti S ct id. SPEC I improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med 1996; 37: 1452-1456.
27. Mann BD, Ciuliano AE, Basset LW et al. Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg 1983; 118: 23-25.
28. Kopans DB. The positive predictive value of mammography. AIR 1992; 158: 521-526.
29. Nagaraj N, Waxman A, Ashok G et al. Comparison of SPECT and planar Tc-99m sestaMIBI imaging in patients with carcinoma of the breast. J Nucl Med 1994; 35: 222P.
30. Nathan MA, Seabold JE, Young DC et al. Planar vs SPECT Tc-99m MIBI evaluation of suspicious breast lesions on mammography: Histologic correlation. J Nucl Med 1994; 35: 222 P.
31. Dgfiles L, Khalkhali I. SPECT prone dependent-breast scintimammography. Eur J Nucl Med 1994: 21: S28.
32. Shek LLM, Godolphin W. Model for breast cancer survival: Relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. Cancer Res 1988; 48: 5565-5569.